Intertek buys Irelands Bioclin

By staff reporter

- Last updated on GMT

Related tags: Good laboratory practice

UK-based quality and safety services firm Intertek has acquired budding Irish services firm Bioclin Research Laboratories.

With a staff of 20, Bioclin conducts contract bio-analysis and analytical research and development, with analytical services including liquid chromatography-tandem mass spectrometry (LC/MS/MS). 

Its facility holds both good laboratory practice (GLP) and good manufacturing practice (GMP) certification. 

Intertek said the purchase "advances its strategic growth in expert support services"​ to the global pharmaceutical, medical device and drug delivery industry. 

Dr John Conti-Ramsden, global director of Intertek's Pharmaceutical Services unit, added that Bioclin "further extends the company's offering in Europe".​ 

Intertek already has laboratory operations in the UK, the US, India and Australia. 

Just over a year ago Intertek made a similar acquisition that gave it a new foothold in the lucrative US market. 

The firm bought Alta Analytical Laboratories, another supplier of immunochemistry and LC/MS/MS bio-analytical services, to the North American biopharma industry. 

Alta had laboratories located in San Diego and near Sacramento, California with around 110 staff. 

At the time of the sale, Intertek was already providing testing services to US pharmaceutical clients from its laboratories in the UK, however, the acquisition of Alta "establishes a firm platform for further development for Intertek in the USA",​ the firm said at the time. 

Meanwhile, Intertek said that newly-bought Bioclin will form part of its Pharmaceutical Services group within its Analytical Services division. 

Mary Burke, managing director and Dr Brian McKenna, scientific director of Bioclin both said that the joining with Intertek will broaden the company's horizons on a global level, and allows it to provide its services to a wider network of new international clients and markets.  Financial terms of the deal were not disclosed.

Related news

Related products

show more

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Related suppliers

Follow us


View more